Search results for "CEM"

showing 10 items of 3487 documents

Hormone Replacement Therapy Associated White Blood Cell DNA Methylation and Gene Expression are Associated With Within-Pair Differences of Body Adipo…

2015

The loss of estrogen during menopause causes changes in the female body, with wide-ranging effects on health. Estrogen-containing hormone replacement therapy (HRT) leads to a relief of typical menopausal symptoms, benefits bone and muscle health, and is associated with tissue-specific gene expression profiles. As gene expression is controlled by epigenetic factors (including DNA methylation), many of which are environmentally sensitive, it is plausible that at least part of the HRT-associated gene expression is due to changes in DNA methylation profile. We investigated genome-wide DNA methylation and gene expression patterns of white blood cells (WBCs) and their associations with body compo…

medicine.medical_specialtyvaihdevuodetmedicine.drug_classHormone Replacement TherapyHRTmenopauseGene ExpressionBiologyBody fat percentageepigenetic regulationBody Mass IndexBone DensityInternal medicineGene expressionmedicineLeukocytesHumansgeeniekspressioEpigeneticsGeneGenetics (clinical)kehonkoostumusAdipositybody compositionta1184skeletal muscle compositionObstetrics and Gynecologyta3141DNA MethylationDNA-metylaatio3. Good healthPostmenopausehormone replacement therapyEndocrinologyDifferentially methylated regionsEstrogenPediatrics Perinatology and Child HealthDNA methylationLean body massFemalediscordant monozygotic twin pair designbone mineral contentGenome-Wide Association StudyTwin research and human genetics : the official journal of the International Society for Twin Studies
researchProduct

Zero-contrast percutaneous coronary interventions to preserve kidney function in patients with severe renal impairment and hemodialysis subjects

2019

Introduction Zero-contrast percutaneous coronary intervention (zero-PCI) is a new method for prevention of contrast-induced acute kidney injury (AKI) in patients with chronic kidney disease (CKD). However, evidence for its feasibility, safety and clinical utility is limited to reports of single cases or series of patients. Aim To present outcomes of zero-PCI in patients with severe CKD, including hemodialysis subjects, who were treated with this procedure in order to preserve their renal function. Material and methods Twenty-nine zero-PCIs were performed, mostly as a staged procedure, in 20 patients with advanced CKD. In this group, 4 patients were treated with hemodialysis but presented pr…

medicine.medical_specialtyzero-contrast percutaneous coronary interventionmedicine.medical_treatmentContrast-induced nephropathylcsh:MedicineRenal function030204 cardiovascular system & hematologyRevascularizationurologic and male genital diseasesrenal insufficiency03 medical and health sciences0302 clinical medicine0502 economics and businessmedicineRenal replacement therapyOriginal Paperbusiness.industrylcsh:R05 social sciencesAcute kidney injuryPercutaneous coronary interventionmedicine.diseaseSurgeryacute kidney injurycontrast-induced nephropathy050211 marketingHemodialysisCardiology and Cardiovascular MedicinebusinessKidney diseasePostępy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology
researchProduct

Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database.

2020

Purpose: To survey risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) practice and advice regarding hormone replacement therapy (HRT) in women with Lynch syndrome. Methods: We conducted a survey in 31 contributing centers from the Prospective Lynch Syndrome Database (PLSD), which incorporates 18 countries worldwide. The survey covered local policies for risk-reducing hysterectomy and BSO in Lynch syndrome, the timing when these measures are offered, the involvement of stakeholders and advice regarding HRT. Results: Risk-reducing hysterectomy and BSO are offered to path_MLH1 and path_MSH2 carriers in 20/21 (95%) contributing centers, to path_MSH6 carriers in 19/21 (91%) and…

medicine.medical_treatmentCàncer d'ovarilcsh:Medicinecomputer.software_genreleikkaushoitoCOLORECTAL-CANCER0302 clinical medicineHormone replacement therapy (female-to-male)munasarjasyöpäMalalties hereditàriesGynecological surgery030219 obstetrics & reproductive medicineManchester Cancer Research CentreDatabaseBrief ReportGeneral MedicineLynch syndrome3. Good healthESTROGENkohdunrungon syöpägynekologiset syövätovarian cancer030220 oncology & carcinogenesisendometrial cancerhormonihoitosyöpätauditHEALTHGenetic disordersGenetic counseling3122 Cancersehkäisevä lääketiede03 medical and health sciencesmedicinerisk-reducing surgeryMedical prescriptionLynchin oireyhtymäperinnölliset tauditHysterectomybusiness.industryResearchInstitutes_Networks_Beacons/mcrcHORMONE REPLACEMENT THERAPYEndometrial cancerlcsh:RInternational survey3126 Surgery anesthesiology intensive care radiologymedicine.diseaseLynch syndromeCàncer d'endometririsk reducing surgerybusinesscomputer
researchProduct

More about genetically modified tumour vaccines

1998

medicine.medical_treatmentGenetic enhancementGene Transfer TechniquesMEDLINEImmunotherapy ActiveGenetic TherapyImmunotherapyBiologyCancer VaccinesGenetically modified organismGeneticsmedicineCancer researchCytokinesHumansMolecular MedicineMolecular BiologyGene Therapy
researchProduct

Dendritic Cell-Specific Biolistic Transfection Using the Fascin Gene Promoter

2012

The transcriptional targeting of gene expression to selected cells by cell type-specific promoters displays a fundamental tool in gene therapy. In immunotherapy, dendritic cells (DCs) are pivotal for the elicitation of antigen-specific immune responses following gene gun-mediated biolistic transfection. Here we report on transcriptional targeting of murine skin DCs using plasmids which include the promoter of the gene of the cytoskeletal protein fascin to control antigen production. Fascin, which is mandatory for the formation of dendrites, is synthesized among the hematopoietic cells exclusively by activated DCs. The activity of the promoter of the fascin gene reflects the endogenous produ…

medicine.medical_treatmentGenetic enhancementchemical and pharmacologic phenomenaPromoterImmunotherapyDendritic cellTransfectionBiologyGene expressionmedicinebiology.proteinCancer researchGeneFascin
researchProduct

Histological study of human periodontal tissue following biologically oriented preparation technique (BOPT)

2020

Background The aim of this study was to conduct histological analysis of a human tooth resected with the periodontal insertion apparatus intact following treatment using biologically oriented preparation technique (BOPT). Material and methods This descriptive histological dento-periodontal study used an anterior tooth extracted with the surrounding periodontal tissues intact, following prosthetic restoration with BOPT. The sample patient was recruited from among those attending the Department of Dental Medicine at the Faculty of Medicine and Dentistry, University of Valencia (Spain). Eight serial sections of the restored tooth were processed. The relative location and histological character…

medicine.medical_treatmentJunctional epitheliumDentistryConnective tissueCase Report02 engineering and technologyCrown (dentistry)03 medical and health sciences0302 clinical medicinestomatognathic systemHuman toothmedicineGeneral DentistryProsthetic Dentistrybusiness.industrySulcular epithelium030206 dentistryPeriodontium021001 nanoscience & nanotechnology:CIENCIAS MÉDICAS [UNESCO]Cementoenamel junctionstomatognathic diseasesmedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASLigament0210 nano-technologybusiness
researchProduct

EMAS position statement: Predictors of premature and early natural menopause.

2019

Simoncini, Tommaso/0000-0002-2971-0079; Chung, Hsin-Fang/0000-0003-3261-5942; Mishra, Gita/0000-0001-9610-5904 WOS:000468709100014 PubMed ID: 31027683 Introduction: While the associations of genetic, reproductive and environmental factors with the timing of natural menopause have been extensively investigated, few epidemiological studies have specifically examined their association with premature (< 40 years) or early natural menopause (40-45 years). Aim: The aim of this position statement is to provide evidence on the predictors of premature and early natural menopause, as well as recommendations for the management of premature and early menopause and future research. Materials and methods…

medicine.medical_treatmentMenopause PrematureTwinsPremature ovarian insufficiencyOVARIAN DEVELOPMENT0302 clinical medicine3123 Gynaecology and paediatricsPregnancyRisk FactorsEpidemiology030212 general & internal medicineFamily historyAetiology030219 obstetrics & reproductive medicineObstetricsEstrogen Replacement TherapySmokingObstetrics and Gynecology3. Good healthEarly menopauseMenopauseParityMenarcheFemaleUnderweightmedicine.symptomMenopausemedicine.medical_specialtyPremature ovarian insufficiencyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesAGEThinnessmedicineHumansPrematureMenarchePregnancyLIFE-COURSEbusiness.industryREPRODUCTIVE PERIODBody Weightmedicine.diseaseCOGNITIVE FUNCTIONBIRTH-WEIGHTAetiology; Early menopause; Premature ovarian insufficiency; Risk factors; Body Weight; Estrogen Replacement Therapy; Female; Humans; Menarche; Pregnancy; Risk Factors; Smoking; Thinness; Twins; Menopause; Menopause Premature; ParityBODY-MASS INDEXRisk factorsRISK-FACTORSHormone therapyCIGARETTE-SMOKINGbusinessSOCIOECONOMIC POSITIONMaturitas
researchProduct

Cement augmentation for trochanteric fracture in elderly: A systematic review()

2021

Abstract Background Cement augmentation of internal fixation of hip fracture has reported to improve fracture stability in osteoporotic hip fractures, reducing the risk of cut-out of the sliding screw through the femoral head. The purpose of present study was to perform a systematic literature review on the effects of augmentation technique in patients with osteoporotic hip fractures. Material and methods A comprehensive literature search was systematically performed to evaluate all papers published in English language included in the literature between January 2010 and July 2020, according to the PRISMA 2009 guidelines. In vivo and in vitro studies, case reports, review articles, cadaveric…

medicine.medical_treatmentOsteoporosisDentistryScrew mobilizationCement augmentation03 medical and health sciencesFemoral head0302 clinical medicinemedicineInternal fixationOrthopedics and Sports Medicine030212 general & internal medicineCut-out risk030222 orthopedicsHip fractureFemur fractureFemur fracturebusiness.industrymedicine.diseasemedicine.anatomical_structureSystematic reviewEditorialHarris Hip ScoreOsteoporosisbusinessCadaveric spasm
researchProduct

Dendritic cells lentivirally engineered to overexpress interleukin-10 inhibit contact hypersensitivity responses, despite their partial activation in…

2010

Background Dendritic cells (DCs) constitute an attractive target for immunotherapeutic approaches. Because DCs are largely refractory to transfection with plasmid DNA, several viral transduction protocols were established. The potential side-effects of lentiviral transduction on the phenotype and activation state of DCs left unstimulated after transduction have not been assessed. There is a need to analyse these parameters as a result of the requirement of using DCs with a low activation state for therapeutic strategies intended to induce tolerance. Methods Lentivirally-transduced bone marrow (BM)-derived DCs (LV-DCs) in comparison with mock-transduced (Mock-DCs) and untreated DCs were anal…

medicine.medical_treatmentT cellGenetic enhancementT-Lymphocyteschemical and pharmacologic phenomenaBiologyLymphocyte ActivationTransduction (genetics)MiceStress PhysiologicalTransduction GeneticDrug DiscoveryGeneticsmedicineAnimalsMolecular BiologyGenetics (clinical)Mice Inbred BALB CInterleukinhemic and immune systemsImmunotherapyTransfectionDendritic CellsCell biologyInterleukin-10Mice Inbred C57BLInterleukin 10Cytokinemedicine.anatomical_structureImmunologyDermatitis Allergic ContactMolecular MedicineFemaleImmunotherapyGenetic EngineeringThe journal of gene medicine
researchProduct

Evaluation of the Oxiris Membrane in Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation Support: Study Protocol for a Single Center, Sin…

2021

Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is the rescue treatment proposed to patients with refractory cardiogenic shock. The VA-ECMO implantation promotes inflammation and ischemia-reperfusion injuries through the VA-ECMO flow, causing digestive mucosa barrier disrupture and inducing translocation of bacterial wall components—Lipopolysaccharides (LPS) with further inflammation and circulatory impairment. LPS is a well-studied surrogate indicator of bacterial translocation. Oxiris membrane is a promising and well-tolerated device that can specifically remove LPS. The main study aim is to compare the LPS elimination capacity of Oxiris membrane vs. a non-absorban…

medicine.medical_treatmentcontinuous renal replacement therapyheart failureoxirisContext (language use)InflammationCardiovascular Medicineartificial membranelaw.inventionStudy ProtocolRandomized controlled triallawmedicineClinical endpointExtracorporeal membrane oxygenationDiseases of the circulatory (Cardiovascular) systemRenal replacement therapycytokines/bloodbusiness.industryCardiogenic shockcardiogenic shockextracorporeal membrane oxygenationmedicine.diseasesurgical procedures operativeendotoxin/bloodRC666-701AnesthesiaHeart failuremedicine.symptomCardiology and Cardiovascular MedicinebusinessFrontiers in Cardiovascular Medicine
researchProduct